Mobile Financial Headlines

Dendreon's Q3 Conference Call happens today

posted 827 weeks ago on The StockMasters - Investing News and Analysis, Hot Stock Tips, Stock Marke
Gentlemen, place your bets.  Dendreon Corporation (NASDAQ: DNDN) will release its third quarter financial results at 1:30 p.m. PT; 4:30 p.m. ET to review financial results and provide a general corporate update. With shares now trading at $6, not $25, it's all on the line and Provenge is the subject of conversation. There isn't a trader in American who doesn't know about Dendreon and the Fool.com called DNDN 'The World's Scariest Stock' last month and the Masters agree.  It's a betting man's game, will the FDA give the green light to Provenge? Provenge is Dendreon's potential Holy Grail, it's an investigational vaccine for the treatment of prostate cancer.  Past tests have shown "significantly improved survival" in men with asymptomatic, metastatic and
Read...

Related Headlines


Search:
Back to Mobile Financial Headlines
Quick Headlines for your mobile phone